Insider Transactions Reported by 10 Insiders of Baudax Bio, Inc.

Location: Malvern, PA

Quick Takeaways

Baudax Bio, Inc. has 10 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are not currently available.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 19 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Baudax Bio, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Yong Chan Kim	Director	$515,278	Mixed	03 Jul 2023
Richard S. Casten	Chief Financial Officer	$509,520	Mixed	20 Aug 2021
Winston J. Churchill	Director	$119,279	Mixed	15 Jun 2022
Wayne Weisman	Director	$109,292	Mixed	15 Jun 2022
William L. Ashton	Director	$108,360	Mixed	15 Jun 2022
Arnold M. Baskies	Director	$106,851	Mixed	15 Jun 2022
Drechsler Andrew T.	Director	$106,123	Mixed	15 Jun 2022
Jillian Dilmore	Corporate Controller/Secretary, PFO and PAO	$40,094	Mixed	15 Jun 2022
Geraldine Henwood	President and CEO, Director	$6,219	Mixed	15 Dec 2022
Natalie McAndrew	Interim CFO		Mixed	09 Oct 2023

Top shareholders of Baudax Bio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Yong Chan Kim	3/4/5	Director	— class O/S missing	202,260	$515,278	—	03 Jul 2023	3/4/5
Richard S. Casten	3/4/5	Chief Financial Officer	— class O/S missing	200,000	$509,520	—	20 Aug 2021	3/4/5
Winston J. Churchill	3/4/5	Director	— class O/S missing	46,820	$119,279	—	15 Jun 2022	3/4/5
Wayne Weisman	3/4/5	Director	— class O/S missing	42,900	$109,292	—	15 Jun 2022	3/4/5
William L. Ashton	3/4/5	Director	— class O/S missing	42,534	$108,360	—	15 Jun 2022	3/4/5
Arnold M. Baskies	3/4/5	Director	— class O/S missing	41,942	$106,851	—	15 Jun 2022	3/4/5
Drechsler Andrew T.	3/4/5	Director	— class O/S missing	41,656	$106,123	—	15 Jun 2022	3/4/5
Jillian Dilmore	3/4/5	Corporate Controller/Secretary, PFO and PAO	— class O/S missing	15,738	$40,094	—	15 Jun 2022	3/4/5
Geraldine Henwood	3/4/5	President and CEO, Director	— class O/S missing	2,441	$6,219	—	15 Dec 2022	3/4/5

Recent Insider Transactions by Companies or Individuals for Baudax Bio, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.